Impurities available for Sunitinib
Search by API Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZImpurities available for Sunitinib
Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase inhibitor that was approved by the FDA for the treatment of renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor on January 26, 2006 Cas No: 557795-19-4 . Anant Labs manufacture and furnish high quality Sunitinib impurities for global markets. Our Sunitinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide. Anant Labs offers Sunitinib impurities.
Total Products : 6
(Page 1 of 1)
